Company intelligence / Profile preview

Lucidome Bio

Wellington, Greater Wellington, New Zealandlucidomebio.com ↗

Ownership: Private
Development stage: Other

Overview

Lucidome Bio is developing a novel vaccine to reduce methane emissions from ruminant animals. The company has received significant funding and international recognition but has not yet reported clinical results as the program remains pre-clinical.

Therapeutic areas: Other
Modalities: Vaccine
Industry: Veterinary

Partnerships

AgResearch (New Zealand research institute; several scientists seconded to Lucidome Bio)

Beyond the preview

Go deeper on Lucidome Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lucidome Bio.

Explore the full profile